Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) changed -0.29% to recent value of $3.38. The stock transacted 25100 shares during most recent day however it has an average volume of 52.58K shares. It spotted trading -44.59% off 52-week high price. On the other end, the stock has been noted 9.03% away from the low price over the last 52-weeks.
On Aug. 11, 2020, Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) a specialty pharmaceutical company focused on hospital acute care and gastroenterology, provided a company update and declared second quarter 2020 financial results. Net revenues from continuing operations during the quarter were $9.6 million. Combined revenues from continued and discontinued operations were $10.3 million, as the company recorded an additional $750,000 in revenue in the second quarter associated with divested product rights.
The Company’s financial position included $98 million in total assets, $49 million of total liabilities, and over $48 million of shareholders’ equity at the end of the quarter.
As the world continues to adapt to a new way of life during the pandemic, we are working hard to manage our business, secure our supply chain and ensure the ongoing delivery of our products to support patient care during these unprecedented times, said A.J. Kazimi, Chief Executive Officer of Cumberland Pharmaceuticals. Our facilities have remained open, and we have continued to operate our business, while working to maintain compliance with the many laws and regulations we fall under as a publicly traded, pharmaceutical company. We continue to make progress toward our goal of building a specialty pharmaceutical business that delivers sustained growth, profitable operations, and long-term value.
CPIX has a gross margin of 80.90% and an operating margin of -12.00% while its profit margin remained -10.30% for the last 12 months. Its earnings per share (EPS) expected to touch remained 48.50% for this year while earning per share for the next 5-years is expected to reach at 30.00%.
The company has 15.24M of outstanding shares and 8.67M shares were floated in the market. According to the most recent quarter its current ratio was 2.3 that represents company’s ability to meet its current financial obligations. The price moved ahead of 2.61% from the mean of 20 days, 2.19% from mean of 50 days SMA and performed -19.76% from mean of 200 days price. YTD performance remained -34.37%.